Table of Contents Author Guidelines Submit a Manuscript
Journal of Nutrition and Metabolism
Volume 2010, Article ID 721365, 9 pages
http://dx.doi.org/10.1155/2010/721365
Review Article

Role of Vitamin D in the Prevention of Pancreatic Cancer

1Department of Internal Medicine, Danbury Hospital, 24 Hospital Avenue, Danbury, CT 06810, USA
2Oncology Unit, 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, Mesogion 152, 11527 Athens, Greece
3GI Oncology Section of the Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Milstein Hospital, Clinical Medicine, Columbia University College of Physicians and Surgeons, Suite 6-435, 177 Fort Washington Avenue, NY 10032, USA

Received 2 September 2010; Revised 12 November 2010; Accepted 14 December 2010

Academic Editor: Christel Lamberg-Allardt

Copyright © 2010 Pubudu Bulathsinghala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Soto, V. M. Barbera, M. Saceda, and A. Carrato, “Molecular biology of exocrine pancreatic cancer,” Clinical and Translational Oncology, vol. 8, no. 5, pp. 306–312, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Vulfovich and C. Rocha-Lima, “Novel advances in pancreatic cancer treatment,” Expert Review of Anticancer Therapy, vol. 8, no. 6, pp. 993–1002, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Berrington De González, E. A. Spencer, H. B. Bueno-De-Mesquita et al., “Anthropometry, physical activity, and the risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 5, pp. 879–885, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. V. Patel, C. Rodriguez, L. Bernstein, A. Chao, M. J. Thun, and E. E. Calle, “Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. cohort,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 2, pp. 459–466, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Luo, M. Iwasaki, M. Inoue et al., “Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan—the JPHC study,” Cancer Causes and Control, vol. 18, no. 6, pp. 603–612, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Raimondi, P. Maisonneuve, and A. B. Lowenfels, “Epidemiology of pancreatic cancer: an overview,” Nature Reviews Gastroenterology and Hepatology, vol. 6, no. 12, pp. 699–708, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Chan, F. Wang, and E. A. Holly, “Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study,” Cancer Causes and Control, vol. 20, no. 6, pp. 835–846, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Moore, D. Goldstein, J. Hamm et al., “Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group,” Journal of Clinical Oncology, vol. 25, no. 15, pp. 1960–1966, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. D. Ahlgren, “Chemotherapy for pancreatic carcinoma,” Cancer, vol. 78, no. 3, pp. 654–663, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. S. A. Cullinan, C. G. Moertel, and T. R. Fleming, “A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin,” Journal of the American Medical Association, vol. 253, no. 14, pp. 2061–2067, 1985. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Ducreux, P. Rougier, J. P. Pignon et al., “A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma,” Annals of Oncology, vol. 13, no. 8, pp. 1185–1191, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. J. H. Klinkenbijl, J. Jeekel, T. Sahmoud et al., “Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group,” Annals of Surgery, vol. 230, no. 6, pp. 776–784, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. R. J. C. Slebos, J. A. Hoppin, P. E. Tolbert et al., “K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study,” Cancer Epidemiology Biomarkers and Prevention, vol. 9, no. 11, pp. 1223–1232, 2000. View at Google Scholar · View at Scopus
  14. J. B. Fleming, G. L. Shen, S. E. Holloway, M. Davis, and R. A. Brekken, “Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy,” Molecular Cancer Research, vol. 3, no. 7, pp. 413–423, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Y. Wei, C. F. Garland, E. D. Gorham, S. B. Mohr, and E. Giovannucci, “Vitamin D and prevention of colorectal adenoma: a meta-analysis,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 11, pp. 2958–2969, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. C. F. Garland, E. D. Gorham, S. B. Mohr et al., “Vitamin D and prevention of breast cancer: pooled analysis,” Journal of Steroid Biochemistry and Molecular Biology, vol. 103, no. 3–5, pp. 708–711, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C. F. Garland, S. B. Mohr, E. D. Gorham, W. B. Grant, and F. C. Garland, “Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer,” American Journal of Preventive Medicine, vol. 31, no. 6, pp. 512–514, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. W. B. Grant, “Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers,” Journal of Photochemistry and Photobiology B, vol. 101, no. 2, pp. 130–136, 2010. View at Publisher · View at Google Scholar
  19. C. F. Garland, E. D. Gorham, S. B. Mohr, and F. C. Garland, “Vitamin D for cancer prevention: global perspective,” Annals of Epidemiology, vol. 19, no. 7, pp. 468–483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. F. Holick, “Resurrection of vitamin D deficiency and rickets,” Journal of Clinical Investigation, vol. 116, no. 8, pp. 2062–2072, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. H. F. DeLuca, “Overview of general physiologic features and functions of vitamin D,” The American journal of clinical nutrition, vol. 80, no. 6, pp. 1689S–1696S, 2004. View at Google Scholar · View at Scopus
  22. C. J. Luscombe, A. A. Fryer, M. E. French et al., “Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer,” Lancet, vol. 358, no. 9282, pp. 641–642, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. E. M. John, J. Koo, and G. G. Schwartz, “Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 6, pp. 1283–1286, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. E. De Vries, I. Soerjomataram, S. Houterman, M. W. J. Louwman, and J. W. W. Coebergh, “Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation?” American Journal of Epidemiology, vol. 165, no. 8, pp. 966–972, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. F. Holick, X. Q. Tian, and M. Allen, “Evolutionary importance for the membrane enhancement of the production of vitamin D in the skin of poikilothermic animals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 8, pp. 3124–3126, 1995. View at Google Scholar · View at Scopus
  26. S. B. Mohr, C. F. Garland, E. D. Gorham, W. B. Grant, and F. C. Garland, “Ultraviolet b irradiance and vitamin d status are inversely associated with incidence rates of pancreatic cancer worldwide,” Pancreas, vol. 39, no. 5, pp. 669–674, 2010. View at Publisher · View at Google Scholar
  27. W. B. Grant and C. F. Garland, “The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates,” Anticancer Research, vol. 26, no. 4A, pp. 2687–2699, 2006. View at Google Scholar · View at Scopus
  28. F. P. Boscoe and M. J. Schymura, “Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002,” BMC Cancer, vol. 6, article no. 264, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Giovannucci, Y. Liu, E. B. Rimm et al., “Prospective study of predictors of vitamin D status and cancer incidence and mortality in men,” Journal of the National Cancer Institute, vol. 98, no. 7, pp. 451–459, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. W. B. Grant, “An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation,” Cancer, vol. 94, no. 6, pp. 1867–1875, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. W. B. Grant, “Ecologic studies of solar UV-B radiation and cancer mortality rates,” Recent Results in Cancer Research, vol. 164, pp. 371–377, 2003. View at Google Scholar · View at Scopus
  32. S. Kinoshita, Y. Wagatsuma, and M. Okada, “Geographical distribution for malignant neoplasm of the pancreas in relation to selected climatic factors in Japan,” International Journal of Health Geographics, vol. 6, article no. 34, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Mizoue, “Ecological study of solar radiation and cancer mortality in Japan,” Health Physics, vol. 87, no. 5, pp. 532–538, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. S. B. Mohr, “A brief history of vitamin d and cancer prevention,” Annals of Epidemiology, vol. 19, no. 2, pp. 79–83, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Fernandez, C. La Vecchia, B. D'Avanzo, and E. Negri, “Menstrual and reproductive factors and pancreatic cancer risk in women,” International Journal of Cancer, vol. 62, no. 1, pp. 11–14, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. W. B. Grant, “How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: an examination using Hill's criteria for causality,” Dermatoendocrinol, vol. 1, no. 1, pp. 17–24, 2009. View at Google Scholar
  37. W. B. Grant and B. J. Boucher, “Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis,” Anticancer Research, vol. 29, no. 9, pp. 3597–3604, 2009. View at Google Scholar · View at Scopus
  38. M. F. Holick, “Vitamin D: a millenium perspective,” Journal of Cellular Biochemistry, vol. 88, no. 2, pp. 296–307, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. W. B. Grant, R. C. Strange, and C. F. Garland, “Sunshine is good medicine. The health benefits of ultraviolet-B induced vitamin D production,” Journal of Cosmetic Dermatology, vol. 2, no. 2, pp. 86–98, 2003. View at Google Scholar
  40. M. F. Holick, “Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis,” American Journal of Clinical Nutrition, vol. 79, no. 3, pp. 362–371, 2004. View at Google Scholar · View at Scopus
  41. W. B. Grant, “Vitamin D and racial disparities for pancreatic cancer—letter,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 3, p. 888, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Giovannucci, “Vitamin D and cancer incidence in the Harvard cohorts,” Annals of Epidemiology, vol. 19, no. 2, pp. 84–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Arabi, R. El Rassi, and G. El-Hajj Fuleihan, “Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes,” Nature Reviews Endocrinology, vol. 6, no. 10, pp. 550–561, 2010. View at Publisher · View at Google Scholar
  44. R. E. Neale, D. R. Youlden, L. Krnjacki, M. G. Kimlin, and J. C. Van Der Pols, “Latitude variation in pancreatic cancer mortality in Australia,” Pancreas, vol. 38, no. 4, pp. 387–390, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. M. F. Holick, “Medical progress: vitamin D deficiency,” New England Journal of Medicine, vol. 357, no. 3, pp. 266–281, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. M. F. Holick, “McCollum award lecture, 1994: vitamin D—new horizons for the 21st century,” American Journal of Clinical Nutrition, vol. 60, no. 4, pp. 619–630, 1994. View at Google Scholar · View at Scopus
  47. T. L. Clemens, J. S. Adams, S. L. Henderson, and M. F. Holick, “Increased skin pigment reduces the capacity of skin to synthesise vitamin D,” Lancet, vol. 1, no. 8263, pp. 74–76, 1982. View at Google Scholar · View at Scopus
  48. A. R. Webb, L. Kline, and M. F. Holick, “Influence of season and latitude on the cutaneous synthesis of vitamin D: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D synthesis in human skin,” Journal of Clinical Endocrinology and Metabolism, vol. 67, no. 2, pp. 373–378, 1988. View at Google Scholar · View at Scopus
  49. L. A. G. Armas, B. W. Hollis, and R. P. Heaney, “Vitamin D is much less effective than vitamin D in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5387–5391, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. M. F. Holick, R. M. Biancuzzo, T. C. Chen et al., “Vitamin D is as effective as vitamin D in maintaining circulating concentrations of 25-hydroxyvitamin D,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 3, pp. 677–681, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. W. E. Stumpf, M. Sar, and F. A. Reid, “Target cells for 1,25-dihydroxyvitamin D in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid,” Science, vol. 206, no. 4423, pp. 1188–1190, 1979. View at Google Scholar · View at Scopus
  52. G. Schwalfenberg, “Not enough vitamin D: health consequences for Canadians,” Canadian Family Physician, vol. 53, no. 5, pp. 841–854, 2007. View at Google Scholar · View at Scopus
  53. H. S. Cross, “Commentary: from epidemiology to molecular biology—vitamin D and colorectal cancer prevention,” International Journal of Epidemiology, vol. 35, no. 2, pp. 225–227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Giovannucci, “The epidemiology of vitamin D and cancer incidence and mortality: a review (United States),” Cancer Causes and Control, vol. 16, no. 2, pp. 83–95, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. E. Giovannucci, “The epidemiology of vitamin D and colorectal cancer: recent findings,” Current Opinion in Gastroenterology, vol. 22, no. 1, pp. 24–29, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. W. B. Grant and M. F. Holick, “Benefits and requirements of vitamin D for optimal health: a review,” Alternative Medicine Review, vol. 10, no. 2, pp. 94–111, 2005. View at Google Scholar · View at Scopus
  57. M. H. Shin, M. D. Holmes, S. E. Hankinson, K. Wu, G. A. Colditz, and W. C. Willett, “Intake of dairy products, calcium, and vitamin D and risk of breast cancer,” Journal of the National Cancer Institute, vol. 94, no. 17, pp. 1301–1311, 2002. View at Google Scholar · View at Scopus
  58. J. Lin, J. E. Manson, I. M. Lee, N. R. Cook, J. E. Buring, and S. M. Zhang, “Intakes of calcium and vitamin D and breast cancer risk in women,” Archives of Internal Medicine, vol. 167, no. 10, pp. 1050–1059, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Bérubé, C. Diorio, B. Mâsse et al., “Vitamin D and calcium intakes from food or supplements and mammographic breast density,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 7, pp. 1653–1659, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. E. R. Bertone-Johnson, W. Y. Chen, M. F. Holick et al., “Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 8, pp. 1991–1997, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. A. C. Porojnicu, Z. Lagunova, T. E. Robsahm, J. P. Berg, A. Dahlback, and J. Moan, “Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway,” Breast Cancer Research and Treatment, vol. 102, no. 3, pp. 323–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. W. B. Grant, “An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking,” International Journal of Cancer, vol. 120, no. 5, pp. 1123–1128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. H. G. Skinner, D. S. Michaud, E. Giovannucci, W. C. Willett, G. A. Colditz, and C. S. Fuchs, “Vitamin D intake and the risk for pancreatic cancer in two cohort studies,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 9, pp. 1688–1695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. I. Chung, W. D. Yu, A. R. Karpf et al., “Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments,” Journal of Steroid Biochemistry and Molecular Biology, vol. 103, no. 3–5, pp. 768–770, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. G. Flynn, I. Chung, W. D. Yu et al., “Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis,” Oncology, vol. 70, no. 6, pp. 447–457, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. K. K. Deeb, D. L. Trump, and C. S. Johnson, “Vitamin D signalling pathways in cancer: potential for anticancer therapeutics,” Nature Reviews Cancer, vol. 7, no. 9, pp. 684–700, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. E. D. Gorham, C. F. Garland, F. C. Garland et al., “Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis,” American Journal of Preventive Medicine, vol. 32, no. 3, pp. 210–216, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. J. M. Lappe, D. Travers-Gustafson, K. M. Davies, R. R. Recker, and R. P. Heaney, “Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial,” American Journal of Clinical Nutrition, vol. 85, no. 6, pp. 1586–1591, 2007. View at Google Scholar · View at Scopus
  69. N. Pendás-Franco, J. M. González-Sancho, Y. Suárez et al., “Vitamin D regulates the phenotype of human breast cancer cells,” Differentiation, vol. 75, no. 3, pp. 193–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. YU. Zheng, H. Zhou, J. R. K. Modzelewski et al., “Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone,” Cancer Research, vol. 67, no. 19, pp. 9542–9548, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. W. B. Grant, H. S. Cross, C. F. Garland et al., “Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe,” Progress in Biophysics and Molecular Biology, vol. 99, no. 2-3, pp. 104–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. W. B. Grant, G. K. Schwalfenberg, S. J. Genuis, and S. J. Whiting, “An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada,” Molecular Nutrition and Food Research, vol. 54, no. 8, pp. 1172–1181, 2010. View at Publisher · View at Google Scholar
  73. C. F. Garland, W. B. Grant, S. B. Mohr, E. D. Gorham, and F. C. Garland, “What is the dose-response relationship between vitamin D and cancer risk?” Nutrition Reviews, vol. 65, no. 8, pp. S91–S95, 2007. View at Google Scholar · View at Scopus
  74. K. C. Chiang and T. C. Chen, “Vitamin D for the prevention and treatment of pancreatic cancer,” World Journal of Gastroenterology, vol. 15, no. 27, pp. 3349–3354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. K. I. Block, A. C. Koch, M. N. Mead, P. K. Tothy, R. A. Newman, and C. Gyllenhaal, “Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials,” Cancer Treatment Reviews, vol. 33, no. 5, pp. 407–418, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. P. Trouillas, J. Honnorat, P. Bret, A. Jouvet, and J. P. Gerard, “Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha-hydroxycholecalciferol,” Journal of Neuro-Oncology, vol. 51, no. 1, pp. 57–66, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. T. C.S. Woo, R. Choo, M. Jamieson, S. Chander, and R. Vieth, “Pilot study: potential role of vitamin D (cholecalciferol) in patients with PSA relapse after definitive therapy,” Nutrition and Cancer, vol. 51, no. 1, pp. 32–36, 2005. View at Publisher · View at Google Scholar
  78. C. Gross, T. Stamey, S. Hancock, and D. Feldman, “Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol),” Journal of Urology, vol. 159, no. 6, pp. 2035–2040, 1998. View at Google Scholar · View at Scopus
  79. C. D. Blanke, T. M. Beer, K. Todd, M. Mori, M. Stone, and C. Lopez, “Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer,” Investigational New Drugs, vol. 27, no. 4, pp. 374–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. A. V. Krishnan, J. Moreno, L. Nonn et al., “Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer,” Journal of Steroid Biochemistry and Molecular Biology, vol. 103, no. 3–5, pp. 694–702, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. J. Moreno, A. V. Krishnan, and D. Feldman, “Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer,” Journal of Steroid Biochemistry and Molecular Biology, vol. 97, no. 1-2, pp. 31–36, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. D. D. Bikle, “Vitamin D regulated keratinocyte differentiation,” Journal of Cellular Biochemistry, vol. 92, no. 3, pp. 436–444, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. T. C. Chen and M. F. Holick, “Vitamin D and prostate cancer prevention and treatment,” Trends in Endocrinology and Metabolism, vol. 14, no. 9, pp. 423–430, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. M. B. Demay, “Mechanism of vitamin D receptor action,” Annals of the New York Academy of Sciences, vol. 1068, no. 1, pp. 204–213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. Zhang, J. Zhang, and G. P. Studzinski, “AKT pathway is activated by 1,25-dihydroxyvitamin D and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells,” Cell Cycle, vol. 5, no. 4, pp. 447–451, 2006. View at Google Scholar · View at Scopus
  86. G. E. Weitsman, R. Koren, E. Zuck, C. Rotem, U. A. Liberman, and A. Ravid, “Vitamin D sensitizes breast cancer cells to the action of H2O2: mitochondria as a convergence point in the death pathway,” Free Radical Biology and Medicine, vol. 39, no. 2, pp. 266–278, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. C. Mathieu and L. Adorini, “The coming of age of 1,25-dihydroxyvitamin D analogs as immunomodulatory agents,” Trends in Molecular Medicine, vol. 8, no. 4, pp. 174–179, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. B. A. Ingraham, B. Bragdon, and A. Nohe, “Molecular basis of the potential of vitamin D to prevent cancer,” Current Medical Research and Opinion, vol. 24, no. 1, pp. 139–149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. K. Z. Guyton, T. W. Kensler, and G. H. Posner, “Vitamin D and vitamin D analogs as cancer chemopreventive agents,” Nutrition Reviews, vol. 61, no. 7, pp. 227–238, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. Y. C. Huang, J. Y. Chen, and W. C. Hung, “Vitamin D receptor/Sp1 complex is required for the induction of p27 expression by vitamin D,” Oncogene, vol. 23, no. 28, pp. 4856–4861, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. M. J. Campbell, A. F. Gombart, S. H. Kwok, S. Park, and H. P. Koeffler, “The anti-proliferative effects of 1α,25(OH)D on breast and prostate cancer cells are associated with induction of BRCA1 gene expression,” Oncogene, vol. 19, no. 44, pp. 5091–5097, 2000. View at Google Scholar · View at Scopus
  92. R. Maruyama, F. Aoki, M. Toyota et al., “Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation,” Cancer Research, vol. 66, no. 9, pp. 4574–4583, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. G. DeMasters, XU. Di, I. Newsham, R. Shiu, and D. A. Gewirtz, “Potentiation of radiation sensitivity in breast tumor cells by the vitamin D analogue, EB 1089, through promotion of autophagy and interference with proliferative recovery,” Molecular Cancer Therapeutics, vol. 5, no. 11, pp. 2786–2797, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. F. C. Campbell, H. Xu, M. El-Tanani, P. Crowe, and V. Bingham, “The Yin and Yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control,” Biochemical Pharmacology, vol. 79, no. 1, pp. 1–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. D. S. Rehder, R. W. Nelson, and C. R. Borges, “Glycosylation status of vitamin D binding protein in cancer patients,” Protein Science, vol. 18, no. 10, pp. 2036–2042, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. G. G. Schwartz, D. Eads, A. Rao et al., “Pancreatic cancer cells express 25-hydroxyvitamin D-1α-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3,” Carcinogenesis, vol. 25, no. 6, pp. 1015–1026, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. F. Pettersson, K. W. Colston, and A. G. Dalgleish, “Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro,” British Journal of Cancer, vol. 83, no. 2, pp. 239–245, 2000. View at Google Scholar · View at Scopus
  98. K. W. Colston, S. Y. James, E. A. Ofori-Kuragu, L. Binderup, and A. G. Grant, “Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro,” British Journal of Cancer, vol. 76, no. 8, pp. 1017–1020, 1997. View at Google Scholar · View at Scopus
  99. D. Gupta, C. A. Lammersfeld, K. Trukova, and C. G. Lis, “Vitamin D and prostate cancer risk: a review of the epidemiological literature,” Prostate Cancer and Prostatic Diseases, vol. 12, no. 3, pp. 215–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. K. Ng, B. M. Wolpin, J. A. Meyerhardt et al., “Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer,” British Journal of Cancer, vol. 101, no. 6, pp. 916–923, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. A. C. Ng, S. K. Kumar, S. V. Rajkumar, and M. T. Drake, “Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma,” American Journal of Hematology, vol. 84, no. 7, pp. 397–400, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. M. T. Drake, M. J. Maurer, B. K. Link et al., “Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma,” Journal of Clinical Oncology, vol. 28, no. 27, pp. 4191–4198, 2010. View at Publisher · View at Google Scholar
  103. J. A. Newton-Bishop, S. Beswick, J. Randerson-Moor et al., “Serum 25-hydroxyvitamin D levels are associated with Breslow thickness at presentation and survival from melanoma,” Journal of Clinical Oncology, vol. 27, no. 32, pp. 5439–5444, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Moan, A. Dahlback, Z. Lagunova, E. Cicarma, and A. C. Porojnicu, “Solar radiation, vitamin D and cancer incidence and mortality in Norway,” Anticancer Research, vol. 29, no. 9, pp. 3501–3509, 2009. View at Google Scholar · View at Scopus
  105. R. Z. Stolzenberg-Solomon, P. Pietinen, P. R. Taylor, J. Virtamo, and D. Albanes, “Prospective study of diet and pancreatic cancer in male smokers,” American Journal of Epidemiology, vol. 155, no. 9, pp. 783–792, 2002. View at Publisher · View at Google Scholar · View at Scopus
  106. H. A. Norman, V. L.W. Go, and R. R. Butrum, “Review of the International Research Conference on Food, Nutrition, and Cancer, 2004,” Journal of Nutrition, vol. 134, supplement 12, pp. 3391S–3393S, 2004. View at Google Scholar
  107. M. Chung, E. M. Balk, S. Ip et al., “Systematic review to support the development of nutrient reference intake values: challenges and solutions,” The American journal of clinical nutrition, vol. 92, no. 2, pp. 273–276, 2010. View at Publisher · View at Google Scholar
  108. M. F. Holick, “High prevalence of vitamin D inadequacy and implications for health,” Mayo Clinic Proceedings, vol. 81, no. 3, pp. 353–373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. H. A. Bischoff-Ferrari, E. Giovannucci, W. C. Willett, T. Dietrich, and B. Dawson-Hughes, “Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes,” American Journal of Clinical Nutrition, vol. 84, no. 1, pp. 18–28, 2006. View at Google Scholar · View at Scopus
  110. M. F. Holick, E. S. Siris, N. Binkley et al., “Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 6, pp. 3215–3224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  111. B. Dawson-Hughes, R. P. Heaney, M. F. Holick, P. Lips, P. J. Meunier, and R. Vieth, “Estimates of optimal vitamin D status,” Osteoporosis International, vol. 16, no. 7, pp. 713–716, 2005. View at Publisher · View at Google Scholar · View at Scopus
  112. K. J. Helzlsouer, “Overview of the cohort consortium vitamin d pooling project of rarer cancers,” American Journal of Epidemiology, vol. 172, no. 1, pp. 4–9, 2010. View at Publisher · View at Google Scholar
  113. Y. Bao, K. Ng, B. M. Wolpin, D. S. Michaud, E. Giovannucci, and C. S. Fuchs, “Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies,” British Journal of Cancer, vol. 102, no. 9, pp. 1422–1427, 2010. View at Publisher · View at Google Scholar · View at Scopus
  114. R. Z. Stolzenberg-Solomon, E. J. Jacobs, A. A. Arslan et al., “Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers,” American Journal of Epidemiology, vol. 172, no. 1, pp. 81–93, 2010. View at Google Scholar
  115. R. Z. Stolzenberg-Solomon, R. B. Hayes, R. L. Horst, K. E. Anderson, B. W. Hollis, and D. T. Silverman, “Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial,” Cancer Research, vol. 69, no. 4, pp. 1439–1447, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. International Agency for Research on Cancer Working Group, Report 5: Vitamin D and Cancer, IARC, Lyon, France, 2008.
  117. W. B. Grant, “Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation,” Dermato-Endocrinology, vol. 1, no. 5, pp. 289–293, 2009. View at Google Scholar
  118. J. Ahn, D. Albanes, S. I. Berndt et al., “Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk,” Carcinogenesis, vol. 30, no. 5, pp. 769–776, 2009. View at Publisher · View at Google Scholar · View at Scopus
  119. R. S. Heist, W. Zhou, Z. Wang et al., “Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 26, no. 34, pp. 5596–5602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  120. S. Petta, C. Cammà, C. Scazzone et al., “Low vitamin d serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C,” Hepatology, vol. 51, no. 4, pp. 1158–1167, 2010. View at Publisher · View at Google Scholar · View at Scopus